Dose-response, Safety and Efficacy of Oral Semaglutide Versus Placebo and Versus Liraglutide, All as Monotherapy in Japanese Subjects With Type 2 Diabetes
Clinical trial NCT03018028 · COMPLETED
Trial details
- NCT number
- NCT03018028
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-10
- Primary completion
- 2018-01-09
- Enrollment
- 243
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.